13F-HR filed by Ridgeback Capital Investments L.P.
Ridgeback Capital Investments L.P. filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 1 holding row worth $560,400.
- Accession
- 0001104659-25-014093
- Filer
- CIK 1423994
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 1 entries on the cover page, a total value of $560,400 stated on the cover page (in dollars after the unit check, H1), rows summing to $560,400 with VALUE read as dollars as filed, 13F file number 028-12856. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerRidgeback Capital Management LLC028-12280
- included managerRidgeback Capital Investments LLC028-12277
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 359,231 | $560,400 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-25-014093 | this filing | 2025-02-14 | acceptance time not in the bulk data set |